【参考文献】
1 Ruilope LM, SalvettiA, Jamerson K, et al.Renal function and intensive
lowering of blood pressure in hypertensive participants of the hypertension optimal treatment(HOT) study.JAm Soc Nephro, 2001, 12(2): 218~225.
2 Martina V,Masha A,Gigliardi VR,et al. LongTerm NAcetylcysteine and LArginine administration reduces endothelialactivation and systolic blood pressure in hypertensive patientswith type 2 diabetesmellitus.DiabetesCare, 2008,2(11): 110~118.
3 Das A, Tanw L, Teo J, et al. Expression of surviving in primary glioblastomas.Cancer Res Clin On col,2002,128(6):302~306.
5 Fukuda N.Development of gene therapies for cardiovascular and renaldiseases by nucleic acid medicines.Medicinal Chemistry,2006,2(1):13~19.
6 Diskin CJ.Minoxidi use in proteinuric renal disease comment. ActaMedica Croatica,2008,62(1):93~98.
7 Villalpando S, Gopal J, Balasubramanyam A, et al. In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis. Am J Clin Nutr,2006,84(1):197~203.
11 Muzio LL, Staibano S, Pannone G, et al. Expression of the apoptosis inhibitior survivin in aggressive squamous cell carcinoma.ExpMol Pathol, 2003,70:249~254.
12 Okada E, Murai Y, Matsui K, et al. Survivin expression in tumour cell nuclei is predicative of a favorable prognosis in gastric cancer patients. Cancer Lett, 2003,163(1):109~116.
13 Kennedy SM, Driscoll O, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer, 2003,88:1077~1083.
14 Cohen C, Lohmann CM, Cotsonis G, et al. Survivin exp ression in ovarian carcinoma: Correlatione with apop totic marker and p rognosis. Mod Pathol, 2003,16 (6): 574~583.
15 Grabowski P, Kuhnel T, Muhr W,kenshoff M, et al. Prognostic value of nuclear survivin expression in oesphageal squamous cell carcinoma. Br J Cancer, 2003,88(1):115~119.